Research ArticlesUrinary Metabolic Profiles for Choosing Test Animals for Chronic Toxicity Studies: Application to Naproxen
References (10)
- et al.
J. Pharm. Sci.
(1972) Anal. Biochem.
(1968)- et al.
J. Med. Chem.
(1970) - et al.
J. Pharmacol. Exp. Ther.
(1971) FDA Pap.
(1968)
There are more references available in the full text version of this article.
Cited by (34)
Profiling urinary metabolites of naproxen by liquid chromatography-electrospray mass spectrometry
2006, Journal of Pharmaceutical and Biomedical AnalysisDetermination of naproxen in human urine by solid-phase microextraction coupled to liquid chromatography
2005, Journal of Pharmaceutical and Biomedical AnalysisEffects of age on the pharmacodynamics of naproxen in the rat
1995, Experimental GerontologySimultaneous quantitative determination of naproxen, its metabolite 6-O-desmethylnaproxen and their five conjugates in plasma and urine samples by high-performance liquid chromatography on dynamically modified silica
1992, Journal of Chromatography B: Biomedical Sciences and ApplicationsMetabolites and analogs of 2‐ethyl‐2,3‐dihydro‐5‐benzofuranacetic acid (furofenac): Chemical and pharmacological properties
1980, Journal of Pharmaceutical SciencesEnantiomeric purity of naproxen by liquid chromatographic analysis of its diastereomeric octyl esters
1979, Journal of Pharmaceutical Sciences
Copyright © 1973 Wiley‐Liss, Inc., A Wiley Company. Published by Elsevier Inc. All rights reserved.